We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

2nd Circ. Tosses Securities Suit Over Bextra, Celebrex

Law360 (January 29, 2009, 12:00 AM EST) -- Former Pfizer Inc. executives have fended off a challenge by shareholders to revive a derivative action over the pharmaceutical makers' marketing of anti-inflammatory drugs Bextra and Celebrex, with an appeals court...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.